Journal of Biological Chemistry · 2009 · 48 citations · 30 references
Life SciencesBiochemistryMolecular BiologyCatalysisEnzyme MechanismEnzymologyCatalytic MechanismsEnzyme Active SitesEnzyme FunctionEnzyme StructureRedox EnzymesStructural EnzymologyCatalytic Residue ConservationEnzyme ActivityEnzyme Reaction MechanismsFlavin CofactorsGeneral Acid-base CatalysisIsomerase CatalysisIsopentenyl Diphosphate BiosynthesisIsopentenyl Diphosphate Isomerase
Using FMN and a reducing agent such as NAD(P)H, type 2 isopentenyl-diphosphate isomerase catalyzes isomerization between isopentenyl diphosphate and dimethylallyl diphosphate, both of which are elemental units for the biosynthesis of highly diverse isoprenoid compounds. Although the flavin cofactor is expected to be integrally involved in catalysis, its exact role remains controversial. Here we report the crystal structures of the substrate-free and complex forms of type 2 isopentenyl-diphosphate isomerase from the thermoacidophilic archaeon Sulfolobus shibatae, not only in the oxidized state but also in the reduced state. Based on the active-site structures of the reduced FMN-substrate-enzyme ternary complexes, which are in the active state, and on the data from site-directed mutagenesis at highly conserved charged or polar amino acid residues around the active site, we demonstrate that only reduced FMN, not amino acid residues, can catalyze proton addition/elimination required for the isomerase reaction. This discovery is the first evidence for this long suspected, but previously unobserved, role of flavins just as a general acid-base catalyst without playing any redox roles, and thereby expands the known functions of these versatile coenzymes. Using FMN and a reducing agent such as NAD(P)H, type 2 isopentenyl-diphosphate isomerase catalyzes isomerization between isopentenyl diphosphate and dimethylallyl diphosphate, both of which are elemental units for the biosynthesis of highly diverse isoprenoid compounds. Although the flavin cofactor is expected to be integrally involved in catalysis, its exact role remains controversial. Here we report the crystal structures of the substrate-free and complex forms of type 2 isopentenyl-diphosphate isomerase from the thermoacidophilic archaeon Sulfolobus shibatae, not only in the oxidized state but also in the reduced state. Based on the active-site structures of the reduced FMN-substrate-enzyme ternary complexes, which are in the active state, and on the data from site-directed mutagenesis at highly conserved charged or polar amino acid residues around the active site, we demonstrate that only reduced FMN, not amino acid residues, can catalyze proton addition/elimination required for the isomerase reaction. This discovery is the first evidence for this long suspected, but previously unobserved, role of flavins just as a general acid-base catalyst without playing any redox roles, and thereby expands the known functions of these versatile coenzymes. Flavins are generally regarded as redox coenzymes because their primary function in redox-catalyzing flavoenzymes is donation and/or acceptance of electrons (1Massey V. Biochem. Soc. Trans. 2000; 28: 283-296Crossref PubMed Google Scholar). As summarized in a review article (2Bornemann S. Nat. Prod. Rep. 2002; 19: 761-772Crossref PubMed Scopus (118) Google Scholar), the redox activities of flavins also take part in the flavoenzymes that catalyze reactions with no net redox change. Most of these enzymes are thought to have redox-based mechanisms, whereas flavins have only structural or stabilizing roles in a few exceptions. Recently, however, a report on UDP-galactopyranose mutase unexpectedly showed that flavin can act as a nucleophilic catalyst (3Soltero-Higgin M. Carlson E.E. Gruber T.D. Kiessling L.L. Nat. Struct. Mol. Biol. 2004; 11: 539-543Crossref PubMed Scopus (125) Google Scholar, 4Miller S.M. Nat. Struct. Mol. Biol. 2004; 11: 497-498Crossref PubMed Scopus (9) Google Scholar). In UDP-galactopyranose mutase, a sugar carbon undergoes nucleophilic attack by the N-5 nitrogen of reduced FMN, concomitantly with the dissociation of UDP, forming an adduct intermediate. In this reaction, the flavin cofactor has no redox function because it is continuously in the reduced state. Type 2 isopentenyl-diphosphate isomerase (IDI) 4The abbreviations used are: IDI, isopentenyl diphosphate:dimethylallyl-diphosphate isomerase; DMAPP, dimethylallyl diphosphate; eIPP, 3,4-epoxy-3-methylbutyl diphosphate; IPP, isopentenyl diphosphate. is the flavoenzyme that catalyzes the interconversion between isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) that occurs with no net change in redox status (5Kaneda K. Kuzuyama T. Takagi M. Hayakawa Y. Seto H. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 932-937Crossref PubMed Scopus (179) Google Scholar). Both compounds are fundamental units for the biosynthesis of isoprenoids, a diverse family of >50,000 metabolites (6Christianson D.W. Science. 2007; 316: 60-61Crossref PubMed Scopus (65) Google Scholar). Type 2 IDI requires FMN, NAD(P)H, and Mg2+ to be active; however, NAD(P)H is used only for the reduction of FMN and can be replaced with Na2S2O4 (7Hemmi H. Ikeda Y. Yamashita S. Nakayama T. Nishino T. Biochem. Biophys. Res. Commun. 2004; 322: 905-910Crossref PubMed Scopus (41) Google Scholar, 8Kittleman W. Thibodeaux C.J. Liu Y.N. Zhang H. Liu H.W. Biochemistry. 2007; 46: 8401-8413Crossref PubMed Scopus (33) Google Scholar, 9Rothman S.C. Helm T.R. Poulter C.D. Biochemistry. 2007; 46: 5437-5445Crossref PubMed Scopus (45) Google Scholar). The observation that reduced FMN is required for type 2 IDI activity allowed for development of various plausible reaction mechanisms, including redox-based mechanisms. Based on the traditional interpretation of the results from the experiments that used cofactor analogues such as 5-deaza-FMN, radical-mediated mechanisms were proposed at first, negating both the hydride transfer mechanism and the merely structural role of FMN (7Hemmi H. Ikeda Y. Yamashita S. Nakayama T. Nishino T. Biochem. Biophys. Res. Commun. 2004; 322: 905-910Crossref PubMed Scopus (41) Google Scholar, 8Kittleman W. Thibodeaux C.J. Liu Y.N. Zhang H. Liu H.W. Biochemistry. 2007; 46: 8401-8413Crossref PubMed Scopus (33) Google Scholar). However, the study using “radical clock” substrate analogues (10Johnston J.B. Walker J.R. Rothman S.C. Poulter C.D. J. Am. Chem. Soc. 2007; 129: 7740-7741Crossref PubMed Scopus (29) Google Scholar) disproved the radical mechanisms, suggesting that the inactivation of type 2 IDI reconstituted with 5-deaza-FMN should be reconsidered with a modern interpretation. Moreover, the measurement of deuterium kinetic isotope effects (11Thibodeaux C.J. Mansoorabadi S.O. Kittleman W. Chang W.C. Liu H.W. Biochemistry. 2008; 47: 2547-2558Crossref PubMed Scopus (32) Google Scholar) strongly supported the non-redox protonation-deprotonation mechanism, which is also utilized by type 1 IDI (12Ramos-Valdivia A.C. van der Heijden R. Verpoorte R. Nat. Prod. Rep. 1997; 14: 591-603Crossref PubMed Scopus (133) Google Scholar). Type 1 enzymes, which are present in nearly all eukaryotes and some bacteria, have no sequential homology with type 2 IDI, which is found in almost all archaea and many bacteria (13Kuzuyama T. Seto H. Nat. Prod. Rep. 2003; 20: 171-183Crossref PubMed Scopus (253) Google Scholar). In type 1 IDI, isomerization proceeds via formation of a 3° carbocation intermediate, and conserved cysteine and glutamate residues act as the general acid or base to mediate (1,3)-antarafacial proton addition/elimination. Hence, there are two possible roles of reduced FMN in type 2 IDI: 1) reduced FMN itself acts as the general acid-base catalyst; and 2) protonation and deprotonation are catalyzed by amino acid residues, and reduced FMN stabilizes the intermediate. The N-5 nitrogen of FMN must be integrally involved in both mechanisms. Although the pKa values of reduced flavins are within the physiological pH range (14Miura R. Chem. Rec. 2001; 1: 183-194Crossref PubMed Scopus (96) Google Scholar, 15Macheroux P. Ghisla S. Sanner C. Ruterjans H. Muller F. BMC Biochem. 2005; 6: 26Crossref PubMed Scopus (44) Google Scholar), there has been no definitive report on the flavoenzymes in which flavin only acts as a general acid-base catalyst without having any redox function. Recent studies of type 2 IDI using substrate analogues such as 3,4-epoxy-3-methylbutyl diphosphate (eIPP), which form adducts with FMN, suggest the possibility that FMN N-5 may act as a general acid or base (10Johnston J.B. Walker J.R. Rothman S.C. Poulter C.D. J. Am. Chem. Soc. 2007; 129: 7740-7741Crossref PubMed Scopus (29) Google Scholar, 16Hoshino T. Tamegai H. Kakinuma K. Eguchi T. Bioorg. Med. Chem. 2006; 14: 6555-6559Crossref PubMed Scopus (33) Google Scholar, 17Rothman S.C. Johnston J.B. Lee S. Walker J.R. Poulter C.D. J. Am. Chem. Soc. 2008; 130: 4906-4913Crossref PubMed Scopus (37) Google Scholar). Based on what is known about the mechanism of UDP-galactopyranose mutase, this theory seems plausible. However, the absence of crystal structures of enzyme-substrate complexes inhibits complete understanding of the role of reduced FMN in type 2 IDI reactions. Here, we report the crystal structures of the substrate-enzyme complexes of type 2 IDI isolated from a thermoacidphilic archaeon, Sulfolobus shibatae, in both the oxidized and reduced state. Combined with results from mutagenic studies that targeted the highly conserved residues, the structural data showed that reduced FMN acts as the general acid-base catalyst. Enzyme Purification-The plasmid for the expression of (His)6-tagged S. shibatae IDI, pET-idi (18Yamashita S. Hemmi H. Ikeda Y. Nakayama T. Nishino T. Eur. J. Biochem. 2004; 271: 1087-1093Crossref PubMed Scopus (36) Google Scholar), was introduced into the Escherichia coli BL21(DE3) strain. The transformant was cultivated in L medium containing 50 mg/liter of ampicillin until cells reached the early stationary phase. The recombinant enzyme was purified with heat treatment at 55 °C for 30 min and a HisTrap column (GE Healthcare) as described previously (18Yamashita S. Hemmi H. Ikeda Y. Nakayama T. Nishino T. Eur. J. Biochem. 2004; 271: 1087-1093Crossref PubMed Scopus (36) Google Scholar). For crystallization, the enzyme was loaded on a HiLoad 16/60 Superdex 200 column (GE Healthcare) and eluted with 10 mm Tris-HCl (pH 7.7), containing 1 mm EDTA, 10 mm β-mercaptoethanol, and 0.15 m NaCl. Crystallization-IDI crystals were grown at 20 °C using the sitting-drop vapor-diffusion method with a reservoir solution containing 0.1 m Tris-HCl (pH 8.0), 0.2 m sodium citrate, and 30% (v/v) polyethylene glycol (PEG) 400. The native crystals were used in the analysis of the substrate-free structure. Crystals for the analysis of the reduced substrate-free structure were obtained by soaking the native crystals in the reservoir solution containing 32% (v/v) PEG 400 and 10 mm NADH. Substrate-complex structures were obtained from the crystals that had been soaked for 1 h in the reservoir solution containing 32% (v/v) PEG 400 and 5 mm IPP or 10 mm DMAPP. Crystals for the analysis of the reduced substrate-complex structures were obtained by the addition of an appropriate amount of Na2S2O4 to the soaking solution containing the substrate. X-ray Data Collection, Structure Solution, and Refinement-All data sets were collected on beamline BL-5A at the photon factory (KEK, Tsukuba, Japan). Complete data sets were collected over contiguous rotation ranges at a given wavelength before proceeding to the next wavelength, and were and with W. 1997; PubMed Scopus Google Scholar). Data are summarized in data sets to with The IDI structure was with crystals using the crystals were obtained by soaking the native crystals for h in the reservoir solution containing 1 mm were using the 1997; PubMed Scopus Google Scholar). by was using the K. and on Scholar). The structure was using P. K. Biol. 2004; PubMed Scopus Google Scholar) and using Biol. 1997; PubMed Scopus Google Scholar), with of the data as a the data was replaced with native data were to FMN, IPP, and were into the on the and in are for the and is the and is the of of of of is the and is the of of in a were introduced into pET-idi using a and in The IDI for the was as previously described (7Hemmi H. Ikeda Y. Yamashita S. Nakayama T. Nishino T. Biochem. Biophys. Res. Commun. 2004; 322: 905-910Crossref PubMed Scopus (41) Google Scholar). of the enzymes were using a Japan). activity of and S. shibatae were using previously described (7Hemmi H. Ikeda Y. Yamashita S. Nakayama T. Nishino T. Biochem. Biophys. Res. Commun. 2004; 322: 905-910Crossref PubMed Scopus (41) Google Scholar). of of forms of and S. shibatae was using the described previously (7Hemmi H. Ikeda Y. Yamashita S. Nakayama T. Nishino T. Biochem. Biophys. Res. Commun. 2004; 322: 905-910Crossref PubMed Scopus (41) Google Scholar). IDI activity the first the enzyme was for complete of the was to 10 mm Tris-HCl (pH 7.7), and was Complete of FMN also was by the of the at from the of the enzyme solution with a Japan). of for IPP and for IPP was from the change in from residues, which results from of the substrate to the The and were and of purified enzyme solution containing of sodium (pH of the purified 5 of FMN, and of was with 10 mm IPP, and the at of with a Japan). The and the of IPP were for the in the of the The data were and using the The is the to which of IPP were to the reaction. and the between the and the were as was utilized for data and 1 the for FMN, that had been as described was of enzyme solution containing of sodium (pH and of the was with Data were and to the FMN for obtained of S. shibatae type 2 IDI substrate-free IDI complexes with IPP and the substrate-free reduced form the in the reduced state and the in the reduced state The structure of was using the wavelength method with the and the structures of type of crystal were The and are in residues, the were not in the and were residues 1 and residues to in the residues and 1 in the residues 2 and 2 in the substrate-complex In all crystal the that are by a which is regarded as the state of S. shibatae IDI in solution (18Yamashita S. Hemmi H. Ikeda Y. Nakayama T. Nishino T. Eur. J. Biochem. 2004; 271: 1087-1093Crossref PubMed Scopus (36) Google Scholar). As in and a isomerase structure previously substrate-free structures of type 2 S. J. S. W. R. A. F. J. Mol. Biol. 2003; PubMed Scopus Google Scholar, J. Rothman S.C. Poulter C.D. J. Biochem. Biophys. Res. Commun. 2005; PubMed Scopus Google Scholar). structural is that and are on the of the isomerase forming a of the active were the The of and the and the structures of which are by the and the also to formation of the active formation is required for of the active of the and S. shibatae IDI active which are the isomerase structure. The of FMN, and of in the substrate-complex were found in all in a However, for was not in the structure was on analysis of IDI crystals that had been soaked in In all FMN were in a by and that the isomerase structure and by and In the the FMN with and of S. shibatae IDI these residues, and which with the of FMN via are at the of and have been the J. Mol. Biol. 2002; PubMed Scopus Google Scholar). The are on the of the isomerase and by and and the of FMN in the complex The IPP and DMAPP, with the of and the of FMN in nearly the via and a Mg2+ which is supported by via a and by is also to the diphosphate of the The and that form the diphosphate Mg2+ and amino acid to to substrate The the isopentenyl or dimethylallyl of the substrate with the of the of in the structures of the forms of S. shibatae IDI are the structures of the active substrate the active is to in the and whereas it is in the structures that are with This from in the of and In addition to the that from substrate and Mg2+ formation between and the change that the of the active structural is to the redox of the In the the nitrogen of is to form with FMN in the the nitrogen of is in the and the of is within formation from FMN N-5 and in the residues, which with FMN which were from in redox were also in such as from M. Y. Biochemistry. 1997; PubMed Scopus Google Scholar). However, in all substrate-complex the of the residues that were with FMN N-5 were to that in the in the oxidized state not should be that isomerase reaction in the reduced the in the and structures are to be a of IPP, DMAPP, and a reaction intermediate. However, both substrate and with residues in the substrate-complex structures were nearly in both the oxidized and reduced Moreover, of the was in whereas the was in In structural studies of reduction of flavin results in Sci. PubMed Scopus Google Scholar). the change in FMN and the of of the crystals are that FMN is in the reduced state in S. shibatae type 2 The change in the was not as in the substrate-complex structures with however, both the of FMN and the isopentenyl or dimethylallyl of the also with the structural mutagenic studies of type 2 IDI were also Based on the previously structures of type 2 from Data and S. J. S. W. R. A. F. J. Mol. Biol. 2003; PubMed Scopus Google and and J. J. Rothman S.C. Poulter J. Biochemistry. 2008; 47: PubMed Scopus Google charged or polar amino acid residues, which are highly conserved known type 2 and to be in the active site, were for mutagenesis amino acid was replaced with to the function of its In the structures of S. shibatae type 2 IDI, all of the residues to be in of FMN and/or the IDI and all for were purified as that results that the not the of the was obtained as an that FMN with however, the of and IDI were nearly that the structure of the had not been by the not As in also IDI activity was reduced in with the In and showed of activity of enzyme suggesting that the residues are for the enzyme reaction. In all for activity of S. shibatae IDI which is a of the enzyme in the absence of the substrate (18Yamashita S. Hemmi H. Ikeda Y. Nakayama T. Nishino T. Eur. J. Biochem. 2004; 271: 1087-1093Crossref PubMed Scopus (36) Google Scholar). This that the inactivation of some enzymes for IDI reaction is not from the in the reduction of FMN by NADH. The of is to its to also the values of enzyme for FMN and IPP by the change in of the for the the amino were not involved in of FMN or for the substrate-enzyme complexes, IPP and are on the of the FMN which that rotation of their reaction is isomerization between IPP and DMAPP, proton occurs at and of IPP to of Poulter C.D. 2004; 6: PubMed Scopus Google Scholar, R. T. C. F. A. F. W. Chem. 2004; 1: PubMed Scopus Google Scholar). In deprotonation and protonation at are R. T. C. F. A. F. W. Chem. 2004; 1: PubMed Scopus Google Scholar, Kittleman W. Zhang H. Seto H. Liu H.W. 2005; PubMed Scopus Google Scholar). and the of carbon of the the in possible proton to the of IPP, and proton from the carbon of in the active were Based on the the N-5 nitrogen of FMN, which is from the carbon of IPP from the carbon of in to be the The nitrogen is because it is from of IPP in the structure from the carbon of in and because the pKa of the proton of reduced flavin was to be which is in the physiological pH range (14Miura R. Chem. Rec. 2001; 1: 183-194Crossref PubMed Scopus (96) Google Scholar, 15Macheroux P. Ghisla S. Sanner C. Ruterjans H. Muller F. BMC Biochem. 2005; 6: 26Crossref PubMed Scopus (44) Google Scholar). However, FMN is the general acid-base the of deprotonation from the of be because the nitrogen is nearly from and of IPP, which to and of DMAPP, should be that FMN is N-5 to IPP in the oxidized The only possible general acid-base catalyst from the structural data is the of which can with of IPP via the of However, this possibility is because the activity of the enzyme and because the is not conserved type 2 IDI The of amino acid residues in acid-base is because all the residues that can act as a general acid-base catalyst or can in a are from of IPP or can be replaced by without we which acts as the proton and for of and IPP, The plausible that may catalyze the protonation of from the of deprotonation of the of FMN which is from the carbon of IPP in the structure from of in possibility is FMN its from of the is in The only FMN was which with the carbon via a Although this possibility was supported by the that the in the role of is because the involved in the is from the carbon of IPP in the The within of the of This the possibility that reduced FMN as amino acid residues in the enzyme act as a general acid-base catalyst for of IPP because the reaction with the In the data from structural and mutagenic studies showed that reduced FMN, not amino acid residues, acts as a general acid-base catalyst in the protonation-deprotonation the role of reduced FMN as a was Although the roles of FMN as acid and/or base have been by expected of general acid-base such as amino acid residues S.C. Helm T.R. Poulter C.D. Biochemistry. 2007; 46: 5437-5445Crossref PubMed Scopus (45) Google Scholar, C.J. Mansoorabadi S.O. Kittleman W. Chang W.C. Liu H.W. Biochemistry. 2008; 47: 2547-2558Crossref PubMed Scopus (32) Google Scholar, S.O. Thibodeaux C.J. Liu H.W. J. Chem. 2007; PubMed Scopus Google Scholar). Type 2 IDI is the first of a flavoenzyme in which flavin was to act as a general acid-base catalyst without any redox function. N-5 nitrogen of FMN seems the plausible for the whereas we not the possibility that of FMN, and be involved in the The role of FMN N-5 as the general acid-base catalyst has been because the pKa for of N-5 of reduced FMN is known to be the that for deprotonation of N-5 is However, it was that formation of the can it to thereby the role of N-5 in the physiological pH range P. Ghisla S. Sanner C. Ruterjans H. Muller F. BMC Biochem. 2005; 6: 26Crossref PubMed Scopus (44) Google Scholar). In S. shibatae type 2 IDI, the of FMN is with at and in both and complex and with via a at in with substrate with charged residues the in the which formation of the flavin Moreover, of the of the at the N-5 nitrogen of reduced FMN, which is to be in the with the nucleophilic of N-5 of reduced FMN in the reaction of UDP-galactopyranose mutase, of the flavin seems For and J. S. 2003; 11: PubMed Scopus Google Scholar) proposed both protonation-deprotonation and radical mechanisms on the structural in the N-5 of FMN also acts as a general acid with no redox function. Although the role of flavin in is it is possible that the mechanisms of and type 2 IDI have the the N-5 nitrogen can act as the acid-base catalyst in the reaction of type 2 IDI, by the flavin it is to catalyze proton addition/elimination. the reaction is to via an intermediate, not in a The carbocation mechanism which the reaction catalyzed by type 1 IDI, seems to the mechanism because the adduct formation between FMN and the substrate analogues such as is by protonation of the by nucleophilic attack by the N-5 nitrogen of reduced FMN (10Johnston J.B. Walker J.R. Rothman S.C. Poulter C.D. J. Am. Chem. Soc. 2007; 129: 7740-7741Crossref PubMed Scopus (29) Google Scholar, 16Hoshino T. Tamegai H. Kakinuma K. Eguchi T. Bioorg. Med. Chem. 2006; 14: 6555-6559Crossref PubMed Scopus (33) Google Scholar, 17Rothman S.C. Johnston J.B. Lee S. Walker J.R. Poulter C.D. J. Am. Chem. Soc. 2008; 130: 4906-4913Crossref PubMed Scopus (37) Google Scholar), and because the in the of the of to the carbon of in the complex structures of the 3° carbocation by the However, it should be that diphosphate, which strongly inhibits type 1 IDI m for IPP as a state Biochemistry. PubMed Scopus Google Scholar, M. Poulter C.D. Biochemistry. PubMed Scopus Google Scholar), is a for IPP for type 2 IDI from T. S.C. Helm T.R. Poulter C.D. Biochemistry. 2007; 46: 5437-5445Crossref PubMed Scopus (45) Google Scholar). the N-5 nitrogen act as the acid-base the nitrogen and are to act as a of with the of reduced In this the mechanism can be whereas the formation of an is also The with via a the protonation of FMN this mechanism, however, it seems to the over of for proton Poulter C.D. 2004; 6: PubMed Scopus Google Scholar, R. T. C. F. A. F. W. Chem. 2004; 1: PubMed Scopus Google Scholar), the complete inactivation of type 2 IDI reconstituted with 5-deaza-FMN (7Hemmi H. Ikeda Y. Yamashita S. Nakayama T. Nishino T. Biochem. Biophys. Res. Commun. 2004; 322: 905-910Crossref PubMed Scopus (41) Google Scholar, 8Kittleman W. Thibodeaux C.J. Liu Y.N. Zhang H. Liu H.W. Biochemistry. 2007; 46: 8401-8413Crossref PubMed Scopus (33) Google Scholar), and the adduct formation of substrate analogues such as with reduced FMN at its N-5 nitrogen (10Johnston J.B. Walker J.R. Rothman S.C. Poulter C.D. J. Am. Chem. Soc. 2007; 129: 7740-7741Crossref PubMed Scopus (29) Google Scholar, 16Hoshino T. Tamegai H. Kakinuma K. Eguchi T. Bioorg. Med. Chem. 2006; 14: 6555-6559Crossref PubMed Scopus (33) Google Scholar, 17Rothman S.C. Johnston J.B. Lee S. Walker J.R. Poulter C.D. J. Am. Chem. Soc. 2008; 130: 4906-4913Crossref PubMed Scopus (37) Google Scholar). is both mechanisms we proposed for type 2 IDI are from the for type 1 IDI W. F. M. R. J. Mol. Biol. 2007; PubMed Scopus Google Scholar) because of their and This strongly that type 2 from many including and are for the of are to for isopentenyl diphosphate and dimethylallyl diphosphate. for the with
30
The PyMOL Molecular Graphics System
Warren L. DeLano · Medical Entomology and Zoology · 2002 · 18.1K citations